OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

ABOUT BREAST CANCER UK ABOUT BREAST CANCER UK 2-6
Our charitable
objectives
3
Our guiding
principles
Impact Report / A word from the Chair and CEO
3
4-5
Working towards
our strategic goals
6
TRUSTEE REPORT:OUR ACTIVITIES AND 7-14
ACHIEVEMENTS
Research projects
Grant programme
8-10
11-14
OUR EDUCATION
PROGRAMME
15-18
Prevention
advice
15
Prevention
Week
16
BCAM 17
Plans for our education
programme
18
OUR GENEROUS SUPPORTERS
Our donors and fundraisers
19-21
19
Philanthropy,
corporate partners
and
legacies 21
OUR ADVOCACY PROGRAMME 22-24
Advocacy and campaigning
Plans for our advocacy and public affairs programme
22
24
FINANCIAL
REVIEW
25-28
STRUCTURE GOVERNANCE AND 28-30
MANAGEMENT
Structure 28
Governance 29
Staff 29-30
Risk Management 30
Statement of Public Benefit 30
ANNUAL
REPORT AND FINANCIAL
31-48
STATEMENTS

Unrestricted Restricted Total Unrestricted Restricted Total
funds t'unde funds funds
2023 2023 2023 2022 2022 2022
Notes
Income from:
Oonations
and
legacies 3 $,433,844 137,44f 1,571,285 857,451 70,144 927,595
Charitable
activities
4 83 - 83
investmenh 5 14,471 14,471 2,279 2,279
Total income 1,448,398 $37,44f 1,585,839 859,730 70,144 929,874
Ex
nditure on:
Raising funds 205,476 205,476 'i44,175 144,175
Charitable
activities
Campaign
costs
141,996 22,550 164,546 84,838 84,838
Education cosh 185,993 18,480 204,473 133,601 18,159 151,760
Science msts 137,235 - 137,235 321,778 321,778
Total charitable
expenditure 465,224 41,030 506,254 540,217 'i8,159 558,376
Total expenditure 670,700 41,030 711,730 684,392 18,159 702,551
Net incoming resources
before transfers 777,698 96,41f 874,109 175,338 51,985 227,323
Gross transfers
behveen
funds
2,994 (2,994) (24,096) 24,096
Net income for the year/
Net movement in funds 780,692 93,417 874,109 151,242 76,081 227,323
Fund balances at 1 April
2022 821,152 57,972 879,124 669,910 (18,109) 651,801
Fund balances at 31
March 2023 1,601,844 151,389 1,753,233 821,152 57,972 879,124

2023 2022
kotes
Current assets
Oebtors 12 38,746 13,372
Cash atbank and inhand 1,932,025 1,147,590
1,970,771 1,160,962
Creditors: amounts falling due within
one year 13 (109,110) (140,319)
Net current assets 1,861,661 1,020,643
Creditors: amounts falling due after
more than one year 14 (108,428) (141,519)
ket assets 1,753,233 879,124
Income funds
Restricted funds 17 151,389 57,972
Unrestricted funds
l3esigriated funds 18 444,000 225,000
General
unrestricted
funds 1,157,844 596,152
1,601,844 821,152
1,753,233 879,124
2II23 2022
Notes
Cash flows from operating activities
Cash generated
from operations
769,964 419,762
Investing activities
Investment
income received
14,471 2,279
Net cash generated
I'rom investing
acttvtt les 14,471 2,279
Net cash used in financing activities
Net increase in cash and cash equivalents 784,435 422,041
Cash and cash equivalents at beginning ofyear 1,147,590 725,549
Cash and cash equivalents at end of year 1,932,025 1,147,590

2023 2022
K
Ticket sales 83
5 Investments
Unrestricted Unrestricted
funds funds
2023 2022
K E
Deposit account irrlerest 14,47'I 2,279
6 Raising funds
Unrestricted Unrestricted
funds funds
2023 2022
E K
Raisin
donations
and acies
consultancy fees 600 26,050
Subscriptions 2,286 1,862
Telephone 497
Printing,
postage
and stationery 2,162 1,953
Promotional activities 20,660 21,929
Sundries 5,360 5,529
Staff costs 109,442 62,315
Donor entry and platform fees 'l9,191 24,040
Total 159,691 144,175
Share of support costs (see note 8) 42,021
Share ofgovernance costs (see note 8) 3,764
205,476 144,175

Campaign Education Science Total Campaign Education Science Total
costs costs costs 2023 costa costa coals 2022
2023 2023 2023 2022 2022 2022
9 9
Sla6'casts 82,415 104,867 271,314 82,498 74,717 89,824 1,96,637
Consultancy fees 596 16,781 t7,977 2,674 15,423 2,073 20,170
ITsoftware snd support costs 560 1.112 355 2,057
Pramalicnal
Subscriptions
activities 2,524
9.211
3PI85
1,074
2,780 9/89
t0,255
1,497
5~
5,905
544
1/59
437
8/St
6/24
Training costs 119 938 1,319 166 336 504
Research aosts 4,994 4,994
Grants 1,039 1,039 205,452 205,452
Recrullrrlnt costs 2,782 1,063 3,835 702 1,244
Peerage and SWionsry 5 5 13 13
Telephone 270 251 4% 987
Prevenfion
hub
2,487 728 4,055 31,825 31,825
f0ck Start a Chernicah 22,550 22,550
Breast Cancer in Men t8,460 18,450
122,664 146,851 90,633 360,148 72,926 130,319 275,721 478,966
Share ofsupport costs (see note 8) 38,119 53/58 42/38 134@5 11302 20,349 43,709 75,360
Share ofgovernance coals (see note 8) 3,763 3,784 3,784 11,291 608 1,092 2,348 4,048
164,545 204,473 137235 505254 84538 151,780 321,7T8 555,378
Analysis
by
fund
Unreslricted funds 141,996 185,993 137,235 465224 84,838 133,601 321,7T8 540,217
Rsstncted funds 22,550 18,480 41,030 18,'l 59 - 18,'!59
Charitable activities (Continued)
164,646 204,473 t37/36 5D6/84 $4,838 151,760 321,778 558,$76
8 Support costs Support Governance 2023 Support Governance 2022
costs costs costs costs
Staff costs 81,939 81,939 56,192 56,192
Staff training,
welfare and
recruitment 9,798 9,798 1,557 1,567
Postage and stationery 724 724 606 606
Travel, accommodation
and meetings 7,351 7,351 852 852
insurance
costs
2,066 2,066 1,784 1,784
Website and ITcosts 58,946 58,946 6,931 6,931
Sundries 2,712 2,712 1,463 1,463
Telephone 3,768 3,768 791 791
Subscrtptions
snd
memberships 3,634 3,634 1,921 1,921
Consuttancy fees 5,768 5,788 3,253 3,253
Finance costs 110 110 'l0 10
Audit Fees 6,600 6,600
Accountancy
Fees
5,354 5,354 3,420 3,420
Legal and professional
fees 2,213 2.213 460
Trusses'
meetings
and
training 888 888 168 168
176,836 15,055 19'I,891 75,360 4,048 79,408
Anafysed
between:
Cost ofRaising Funds 42,021 3,764 45,785
Charitable
activities
134,815 11,29'I 146,106 75,360 4,048 79,408
176,836 15,055 191,891 75,360 79,408

The average monthly
num
ber ofemploye es
during the
year was:
2023 2N2
Number Number
Management and administration
Fundraistng
Campaigns, Science and Education
Total
Employment costs 2023 2N2
Wages and salaries 419,754 292,377
Social security costs 29,517 15,989
Other pension costs 13,424 6,978
462,695 316,344
The number ofemployees whose annual remuneration was more than 260,000
isas follows:
2023 2922
Number Number
f70,0G'l - EM,OOG

Debtors
2023 2022
Amounts
falling due within one year:
Monies owed 12,183 514
Other debtors 24,889 'l1,184
Prepayments and accrued incame 1,674 1,674
38,746 13,372

13 Creditors: amou nts falling due within on e year
2023 2022
Other taxation and social security 1,559
Trade creditors 15,414 4,191
Grants payable 83,769 122,944
Accruals and deferred income 9,927 t1,625
109,1'l 0 140,319
14 Creditors: amounts falling due after more than one year
2023 2022
Notes E
Deferred grants 108,428 141,519
15 Deterred income
2023 2022
R
Deferred grants 108,428 141,519
Deferred inmme isincluded in the financial statements as follows:
2023 2022
R
Deferred income is included within;
Non~rrent
liabiliTies
'f08,428 141,519
Movemente
in the year:
Deferred income at 1 April 2022 $41,519 8,672
Released from previous periods (33,091) (8,672)
Resouices deferred in the year 141,519
Deferred income at 31 March 2023 $08,428 141,519

17 Restricted funds Restricted funds
The income funds ofthe charity include restricted tunds oompnsing the forewing unexpended balances ofdonalions
and grards held on trust for
specilio purposes;
frfcntentent in fttnds Nlcntentent
in htrtth
uetenee it tneew lie
tteeowsin
aelinee ~t
lncewllle
tteeoltwee Tlitlefile
Selenee et
1 April 202'l wiowcex
expended
1ApN 2S22
wiowcei
expended S'l March 2022
6 6 6
6
Breast Density Reseatoh Project (4,746) 7,740 2,994 (2,994)
Oxrsfarots Proptct
Creation and dtnattopment
ofDLT
Young pecqje educatonal
resource
(24,608)
11~
512
7,000
fT,570
(18,159)
24,096 86
fT,570
30,0X
(66)
4T,570
Breast cancer In men resource
Biephenols research project
Chemicals~t
17,570
19,752
17,670
19,752
2@91
50
25,DX
(16,450)
(22,550)
56
1,587
19,802
2,450
General science research 80,000 80,900
(18,1D9) 70,144
(18,159)
24,D96 f37,441 (41,030) (2 tt94)
151,$59
18 Oesignated
funds
The income funds of the charity include the following designated funds which
have
been set aside out of
unrestricted
funds by the trustees
for spedfic purposes.
Movement
in
funds
Bstjanca ftt Transfers Mama stt Incofnlrtg Rasattrcas BfstttntMt
ttt
1 Aprtt 2(I21 1 April 2022 resources expended N Njareh 202$
Science Grant Budget 100,000 100,000 200,000 220000 420,000
CRM Development 25,000 25,000 (25,000)
Conversion
ofOnline
Quiz
10,000 10,000
HRT Scientific brief 9,000 9,000
Breast Feeding resource 5,000 5,000
100,000 125,000 225,000 244,000 (25,000)
444,000
19 Analysis of net assets between funds
Unresbicled Restricted Total Unrestricted
Restricted
Total
funds funds funds ftj(nds
2023 2023 2023 2022 2022 2022
K K
Fund balances at 31
March 2023 are
represented
by:
Current assets/(liabilities) 1,677,'i82 184,479 1,861,661 896,490 f24,153 1,020,643
Long term liabiliTies (75,338) (33,090) (108,428) (75,338) (66,18'I) (141,519)
't,601,844 'I51,389 1,753333 821,152 57,972 879,124
Cash generated
from operations
Cash generated
from operations
2023 2022
K
Surplus for the year 874,109 227,323
Adjustments
for.
Investment
income recognised
in statement offinancial activities ($4,471) (2,279)
Movements
in wo(fdng capital-.
(increase) in debtors ('i3,364) (13,372)
(Decrease)/increase
in creditors
(31,209) 140,319
(Decrease)jtncrease
in deferred
income (33,091) 141,519
Cash generated
from operatio
ns 781,974 517,550